Showing results (231-240 of 279) with videos related to
Sort By:
Pageof 28
Endoscopy|June 8, 2007
The utility of contrast-enhanced endoscopic ultrasound in monitoring ethanol-induced pancreatic tissue ablation: a pilot study in a porcine modelS A Giday, P Magno, K L Gabrielson, et al.Journal of the American Chemical Society|November 15, 2002
The practical synthesis of a novel and highly potent analogue of bryostatinPaul A Wender, Jeremy L Baryza, Chad E Bennett, et al.Endoscopy|December 14, 2006
Is blood the ideal submucosal cushioning agent? A comparative study in a porcine modelS A Giday, P Magno, J M Buscaglia, et al.Bioorganic & Medicinal Chemistry Letters|May 24, 2011
Novel, potent, and orally bioavailable phosphinic acid inhibitors of the hepatitis C virus NS3 proteaseMichael O Clarke, Xiaowu Chen, Aesop Cho, et al.Endoscopy|May 15, 2008
Severity of post-ERCP pancreatitis directly proportional to the invasiveness of endoscopic intervention: a pilot study in a canine modelJ M Buscaglia, B W Simons, B J Prosser, et al.JOP : Journal of the Pancreas|July 24, 2008
Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in caninesJonathan M Buscaglia, Brian W Simons, Brent J Prosser, et al.Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|February 22, 2025
Supportive care for systemic amyloidosis: International Society of Amyloidosis (ISA) expert panel guidelinesEli Muchtar, Martha Grogan, Fabian Aus dem Siepen, et al.Gastrointestinal Endoscopy|August 9, 2015
Refractory gastroparesis can be successfully managed with endoscopic transpyloric stent placement and fixation (with video)Mouen A Khashab, Sepideh Besharati, Saowanee Ngamruengphong, et al.Journal of Clinical Gastroenterology|January 16, 2024
Quality Indicator Development for the Approach to Ineffective Esophageal Motility: A Modified Delphi StudyAfrin N Kamal, Priya Kathpalia, David A Leiman, et al.Bioorganic & Medicinal Chemistry Letters|January 17, 2012
Discovery of GS-9256: a novel phosphinic acid derived inhibitor of the hepatitis C virus NS3/4A protease with potent clinical activityX Christopher Sheng, Anthony Casarez, Ruby Cai, et al.Pageof 28